These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8469272)

  • 1. Japan reviews first guidelines for gene therapy trials.
    Swinbanks D
    Nature; 1993 Apr; 362(6422):684. PubMed ID: 8469272
    [No Abstract]   [Full Text] [Related]  

  • 2. Health Sciences Council of Japan adopts guidelines for gene therapy clinical research.
    Int Dig Health Legis; 1995; 46(4):560-3. PubMed ID: 11657358
    [No Abstract]   [Full Text] [Related]  

  • 3. Special informed consent requirements are included in protocol review procedures.
    Maloney DM
    Hum Res Rep; 1995 Jul; 10(7):1-2. PubMed ID: 11654274
    [No Abstract]   [Full Text] [Related]  

  • 4. Trends in gene therapy regulation.
    Lecomte V; Taylor A
    Gene Ther; 1997 Feb; 4(2):77-8. PubMed ID: 11644906
    [No Abstract]   [Full Text] [Related]  

  • 5. Japan sets up gene therapy panel.
    Swinbanks D
    Nature; 1994 Feb; 367(6463):502. PubMed ID: 8107816
    [No Abstract]   [Full Text] [Related]  

  • 6. Beyond localism: a proposal for a National Research Review Board.
    Levine C; Caplan AL
    IRB; 1986; 8(2):7-9. PubMed ID: 11649751
    [No Abstract]   [Full Text] [Related]  

  • 7. Korea leaps before it looks over gene therapy guidelines.
    Swinbanks D
    Nature; 1997 May; 387(6628):6. PubMed ID: 9139811
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethical oversight of research in developing countries.
    Kass N; Dawson L; Loyo-Berrios NI
    IRB; 2003; 25(2):1-10. PubMed ID: 12833901
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethics in evolution.
    Huston P
    CMAJ; 1996 Aug; 155(4):363. PubMed ID: 11654512
    [No Abstract]   [Full Text] [Related]  

  • 10. Toward a more comprehensive approach to protecting human subjects: the interface of data safety monitoring boards and institutional review boards in randomized clinical trials.
    Gordon VM; Sugarman J; Kass N
    IRB; 1998; 20(1):1-5. PubMed ID: 11655324
    [No Abstract]   [Full Text] [Related]  

  • 11. Fears mount for gene scrutiny as watchdog faces axe.
    Kiernan V
    New Sci; 1996 Jun; 150(2033):10. PubMed ID: 11656540
    [No Abstract]   [Full Text] [Related]  

  • 12. Japan to ban human cloning.
    Saegusa A
    Nat Med; 1998 Sep; 4(9):993. PubMed ID: 11645100
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene therapy gets double dose of screening.
    Swinbanks D
    Nature; 1994 Feb; 367(6462):399. PubMed ID: 8107783
    [No Abstract]   [Full Text] [Related]  

  • 14. Foresight, insight, oversight.
    White GB
    Hastings Cent Rep; 1999; 29(2):41-2. PubMed ID: 10321343
    [No Abstract]   [Full Text] [Related]  

  • 15. Japan edges cautiously towards gene therapy.
    Nature; 1994 Jul; 370(6487):243. PubMed ID: 8035865
    [No Abstract]   [Full Text] [Related]  

  • 16. Review panel cancels meeting as gene therapy proposals fall.
    Wadman M
    Nature; 1996 Feb; 379(6567):668. PubMed ID: 11644770
    [No Abstract]   [Full Text] [Related]  

  • 17. Proposed requirements for informed consent go beyond current federal regulations.
    Hum Res Rep; 1994 Jul; 9(7):1-3. PubMed ID: 11659879
    [No Abstract]   [Full Text] [Related]  

  • 18. Guidelines for confidentiality in research on AIDS.
    Bayer R; Levine C; Murray TH
    IRB; 1984; 6(6):1-7. PubMed ID: 11649192
    [No Abstract]   [Full Text] [Related]  

  • 19. Ethics of clinical trials for research ethics boards: proceedings of a national workshop.
    National Council on Bioethics in Human Research (Canada)
    NCBHR Commun; 1991; 2(2):4-23. PubMed ID: 11659919
    [No Abstract]   [Full Text] [Related]  

  • 20. Guidelines may boost gene therapy in Japan.
    Barker S
    Nature; 1995 Nov; 378(6555):327. PubMed ID: 7477360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.